SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-20-264799
Filing Date
2020-10-06
Accepted
2020-10-06 16:41:59
Documents
4
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A d95577d10qa.htm 10-Q/A 27822
2 EX-10.6 d95577dex106.htm EX-10.6 291683
3 EX-31.1 d95577dex311.htm EX-31.1 3093
4 EX-31.2 d95577dex312.htm EX-31.2 3046
  Complete submission text file 0001193125-20-264799.txt   326881
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38443 | Film No.: 201227185
SIC: 2834 Pharmaceutical Preparations